Globally, nearly half of deaths from cirrhosis and chronic liver diseases (CLD) and three-
quarters of deaths from hepatocellular carcinoma (HCC) occur in the Asia-Pacific region …

Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …

Background Broad direct-acting antiviral (DAA) access may reduce hepatitis C virus (HCV)
incidence through a" treatment as prevention"(TasP) effect. We assessed changes in …

Abstract Background & Aims Detecting hepatitis C virus (HCV) reinfection among key
populations helps prevent ongoing transmission. This systematic review aims to determine …

Background Understanding the risk behaviors associated with sexually-transmitted hepatitis
C virus (HCV) infection among men who have sex with men (MSM) may inform the public …

Background Gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) are at
increased risk for sexually transmissible infections. Hepatitis C virus (HCV) risk among PrEP …

To reach the WHO target of hepatitis C virus (HCV) elimination by 2025, Taiwan started to
implement free-of-charge direct-acting antiviral (DAA) treatment programme in 2017 …

Background Data on hepatitis C virus (HCV) reinfection in East Asian people with HIV after
treatment-induced sustained virologic response (SVR) are limited. Methods HIV/HCV …

Background: Injecting drug use is purportedly more common among gay and bisexual men
(GBM) than the general Australian population. Approaches designed to support the …

The overlapping epidemics of hepatitis C virus (HCV) and HIV infection stem from
underlying behaviors and health disparities among disproportionately affected populations …